Biochemistry Quiz: Protein Kinases Phosphatases And Phosphorylation Cascades

What this quiz covers

This quiz focuses on Protein Kinases Phosphatases And Phosphorylation Cascades, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Replacing the serine residue with a threonine residue.
2. Replacing one of the arginine residues with a lysine residue.
3. Replacing the serine residue with an aspartate residue. (correct answer)
4. Replacing the large hydrophobic residue at position Y with a different large hydrophobic residue (e.g., leucine to isoleucine).

Explanation: The kinase requires a serine (or threonine) to phosphorylate. Replacing the target serine with aspartate (C) removes the hydroxyl group necessary for phosphorylation and introduces a negative charge, which would likely repel the kinase's active site. This would abolish phosphorylation. Replacing serine with threonine (A) might be tolerated, as many kinases can phosphorylate either. Replacing arginine with lysine (B) maintains the positive charge that is likely important for recognition and may be tolerated. Replacing one hydrophobic residue with another similar one (D) is also likely to be tolerated. The most disruptive change is the removal of the phosphorylatable residue itself.

Question 2

1. Both mutants will be inactive, as any change to the critical threonine residue disrupts the active site conformation required for catalysis.
2. The T185A mutant will be constitutively active, while the T185E mutant will be inactive, mimicking the unphosphorylated state.
3. The T185A mutant will be inactive because it cannot be phosphorylated, while the T185E mutant will be constitutively active because glutamate's negative charge mimics a phosphate group. (correct answer)
4. The T185E mutant will be inactive due to steric hindrance from the larger side chain, while the T185A mutant will show low basal activity that cannot be upregulated.

Explanation: Phosphorylation adds a bulky, negatively charged phosphate group. Alanine (T185A) is a small, non-polar amino acid and lacks a hydroxyl group, so it cannot be phosphorylated, rendering the kinase inactive. Glutamate (T185E) has a negatively charged carboxylate side chain, which often serves as a 'phosphomimetic,' structurally and electrostatically mimicking the phosphorylated state. This typically results in a constitutively active kinase. Therefore, T185A is inactive, and T185E is constitutively active. This is a common strategy in cell biology to study protein function.

Question 3

1. High cellular AMP levels combined with an inhibitor of PP2A.
2. Low cellular AMP levels combined with an inhibitor of PP2A.
3. High cellular AMP levels combined with an activator of AMPK.
4. Low cellular AMP levels combined with an inhibitor of AMPK. (correct answer)

Explanation: We want to maximize mTORC1 activity. mTORC1 is active when it is NOT phosphorylated by AMPK. 1) Low cellular AMP levels will lead to low AMPK activity. 2) Directly inhibiting AMPK will also lead to low AMPK activity. This prevents the inhibitory phosphorylation of mTORC1. 3) An inhibitor of PP2A (A, B) would actually decrease mTORC1 activity by preventing its re-activation. High AMP (A, C) would activate AMPK, which would inhibit mTORC1. Therefore, the condition that maximally activates mTORC1 is low energy-stress signals (low AMP) and direct inhibition of its upstream inhibitor (AMPK). This leads to the highest phosphorylation of its targets like S6K.

Question 4

1. Phosphorylation will be inhibited because GTPγS cannot provide the energy for signal transduction.
2. Phosphorylation will be transiently activated and then rapidly terminated as normal.
3. Phosphorylation will be constitutively high because the G-protein will be locked in its active, GTP-bound state. (correct answer)
4. There will be no effect on phosphorylation unless a ligand is also added to activate the GPCR.

Explanation: GTPγS can bind to G-proteins but cannot be hydrolyzed to GDP. This locks the G-protein in its active state. An active Gα subunit continuously activates adenylyl cyclase, leading to constant production of cAMP. This, in turn, keeps PKA constitutively active, resulting in sustained, high-level phosphorylation of its targets. This happens even without a ligand because there is a basal level of G-protein activation that is normally terminated by GTP hydrolysis. Locking this active state on bypasses the need for constant receptor stimulation.

Question 5

1. Approximately 10-fold above basal levels because the initial stimulus maintains the elevated state
2. Approximately at basal levels because negative feedback completely counteracts the initial stimulus
3. Approximately 2-3 fold above basal levels because negative feedback partially but not completely counteracts the stimulus (correct answer)
4. Approximately zero activity because the negative feedback creates a complete shutdown of kinase function

Explanation: The correct answer is C. In negative feedback systems, the steady state represents a balance between the activating stimulus and the feedback inhibition. The feedback doesn't completely eliminate the response but dampens it significantly. A new equilibrium is reached where kinase Z activity is elevated enough to maintain some phosphatase Y activity, but much less than the initial 10-fold spike. A is incorrect because negative feedback would reduce the elevated activity. B is incorrect because some elevation above basal is needed to maintain the phosphatase activity that provides the feedback. D is incorrect because complete shutdown would eliminate the feedback signal, allowing kinase reactivation.

Question 6

1. A widespread shutdown of phosphorylation-dependent signaling pathways, leading to effects such as cell cycle arrest or apoptosis. (correct answer)
2. A global increase in protein phosphorylation, as phosphatases become hyperactive to compensate for the lack of kinase activity.
3. A specific inhibition of only receptor tyrosine kinases, while cytosolic serine/threonine kinase cascades remain unaffected.
4. An accumulation of ATP within the cell, leading to the activation of energy-sensing pathways like AMPK.

Explanation: When you encounter questions about broad-spectrum enzyme inhibitors, focus on the direct consequences of blocking that enzyme's primary function throughout the cell. Staurosporine blocks the ATP-binding site of protein kinases, preventing them from transferring phosphate groups to target proteins. Since protein kinases are essential components of virtually every cellular signaling pathway—from growth factor signaling to cell cycle control to apoptosis regulation—inhibiting them causes a cascade of disrupted cellular processes. Without functional kinases, cells cannot properly respond to external signals, progress through the cell cycle, or maintain normal metabolic functions. This widespread disruption typically triggers protective mechanisms like cell cycle arrest or programmed cell death, making A correct. B is incorrect because phosphatases don't become "hyperactive" to compensate—they continue working at normal rates, but without opposing kinase activity, overall phosphorylation levels actually decrease, not increase. C misrepresents staurosporine's mechanism; it's explicitly described as non-selective, meaning it inhibits both receptor tyrosine kinases and serine/threonine kinases equally. D confuses cause and effect—while ATP might accumulate slightly since kinases aren't consuming it, this wouldn't be the primary effect, and AMPK activation requires specific cellular stress signals, not just ATP abundance. Study tip: For enzyme inhibitor questions, always trace the immediate biochemical consequence first (blocked enzyme function), then follow the downstream cellular effects. Non-selective inhibitors affecting central processes like phosphorylation typically have dramatic, cell-wide impacts.

Question 7

1. The signal will be attenuated because the mutant PPX sequesters Kinase 2, preventing its activation by Kinase 1.
2. The signal will be prolonged and amplified because the mutant PPX acts as a substrate competitor, protecting phosphorylated Kinase 2 from dephosphorylation by any remaining wild-type PPX. (correct answer)
3. The pathway will be completely blocked because the binding of inactive PPX to Kinase 2 allosterically inhibits its kinase activity.
4. There will be no significant change in signaling, as the lack of phosphatase activity is compensated for by the natural decay of the phosphorylated state.

Explanation: The mutant, catalytically inactive PPX still binds to the substrate, Kinase 2. By doing so, it acts as a competitive inhibitor for the endogenous, active phosphatase. This 'protects' the phosphorylated, active form of Kinase 2 from being inactivated. The result is a signal that lasts longer and is effectively amplified because the active state of Kinase 2 persists. (A) is incorrect because PPX binds to Kinase 2, not necessarily preventing its phosphorylation by Kinase 1. (C) is unlikely; binding of a phosphatase does not typically inhibit the kinase activity of its substrate. (D) is incorrect because dephosphorylation is an enzyme-catalyzed process, not a rapid spontaneous decay, and its inhibition has significant effects.

Question 8

1. Each ligand-receptor binding event causes the synthesis of multiple new kinase molecules, increasing the total enzyme concentration.
2. A single active kinase is an enzyme that can catalyze the phosphorylation of hundreds or thousands of downstream substrate molecules, each of which then becomes active. (correct answer)
3. Phosphatases are progressively inhibited as the cascade proceeds, allowing phosphorylated proteins to accumulate exponentially.
4. The binding of a second messenger like cAMP to a kinase allosterically increases its affinity for ATP, leading to a much higher catalytic rate.

Explanation: The primary mechanism for amplification is the catalytic nature of the enzymes in the cascade. One activated kinase can phosphorylate many molecules of the next kinase in the series. Since each of those newly activated kinases can, in turn, phosphorylate many of its own substrates, the signal expands exponentially at each step. (A) is incorrect; amplification occurs via post-translational modification, not new protein synthesis, which is much slower. (C) is a mechanism for prolonging a signal but is not the primary mechanism of amplification. (D) describes an activation mechanism but does not explain the multiplicative amplification that occurs across multiple tiers of a cascade.

Question 9

1. It will have no effect, as the wild-type receptors in the dimers can still phosphorylate their targets and initiate the signal.
2. It will cause constitutive activation of the pathway, as the mutant receptor permanently sequesters phosphatases.
3. It will function as a dominant negative inhibitor, forming non-productive heterodimers with wild-type receptors and reducing overall signal output. (correct answer)
4. It will increase signal sensitivity, as the mutant receptor can still bind the ligand and recruit downstream adaptors more efficiently.

Explanation: The catalytically dead mutant can still bind the ligand and dimerize with wild-type receptors. However, in such a heterodimer, the mutant cannot phosphorylate the wild-type, and the wild-type may phosphorylate the mutant, but the mutant cannot propagate the signal. Because the mutant receptor effectively 'poisons' the function of the wild-type receptor it pairs with, it reduces the number of functional signaling dimers and acts as a dominant negative inhibitor.

Question 10

1. A negative feedback loop where the activation of Kinase B ultimately leads to the deactivation of Kinase A.
2. A positive feedback loop where the activation of Kinase A leads to its own sustained activation by inhibiting its inactivating phosphatase. (correct answer)
3. A feed-forward circuit where Kinase A primes the system for prolonged signaling by simultaneously activating its target and inhibiting its own brake.
4. An incoherent loop where Kinase A activates one branch that promotes its activity and another branch that indirectly inhibits its activity.

Explanation: This describes a positive feedback loop. 1) Kinase A becomes active. 2) Kinase A activates Kinase B. 3) Kinase B inhibits PP1. 4) PP1 is the phosphatase that inactivates Kinase A. 5) By inhibiting PP1, the pathway prevents the inactivation of Kinase A, thus sustaining its own activity. This creates a self-reinforcing, switch-like behavior. It is not negative feedback (A) because the end result is more Kinase A activity, not less. It is a form of feed-forward logic (C), but the more specific and important description is positive feedback because the signal loops back to reinforce the initial step.

Question 11

1. The phosphorylation and activity of p90RSK will decrease because inhibiting PP2A disrupts the normal recycling of signaling components.
2. There will be no change in p90RSK phosphorylation because without growth factor stimulation, ERK is not phosphorylated and therefore inactive.
3. The phosphorylation and activity of p90RSK will increase because the inhibition of PP2A leads to an accumulation of active, phosphorylated ERK. (correct answer)
4. The total amount of p90RSK protein will increase due to a compensatory transcriptional response to phosphatase inhibition.

Explanation: Even in the absence of stimulation, there is a basal level of kinase and phosphatase activity creating a steady-state level of phosphorylation. By inhibiting the phosphatase (PP2A) that inactivates the kinase (ERK), the balance is shifted. Phosphorylated, active ERK will accumulate. This active ERK will then phosphorylate its downstream targets, like p90RSK, leading to an increase in their phosphorylation and activity, even without an external stimulus. (B) is incorrect because it ignores the basal activity that is kept in check by phosphatases. (A) is incorrect as inhibition of a phosphatase generally increases, not decreases, phosphorylation. (D) describes a much slower, long-term response, not an immediate effect.

Question 12

1. It increases signal amplification by increasing the Vmax of each kinase in the cascade through allosteric activation.
2. It provides spatial organization, increasing the efficiency and specificity of signal transmission by preventing cross-talk with other pathways. (correct answer)
3. It terminates the signal by recruiting specific protein phosphatases to the complex once the downstream target is phosphorylated.
4. It transports the entire kinase complex from the cytoplasm to the nucleus to allow for direct phosphorylation of transcription factors.

Explanation: The main role of a scaffold is to bring the components of a pathway into close proximity. This increases the effective concentration of enzyme and substrate, making the signal transmission much more efficient (faster). It also enhances specificity by physically insulating the bound kinases from interacting with inappropriate substrates or activators from other parallel pathways in the cytoplasm. While some scaffolds might have other roles (C, D), their primary and defining function is spatial organization. Scaffolds do not typically alter the intrinsic Vmax of the enzymes they bind (A).

Question 13

1. It activates adenylyl cyclase to produce more cAMP in a positive feedback loop.
2. It dephosphorylates glycogen synthase, leading to the activation of glycogen synthesis.
3. It phosphorylates glycogen phosphorylase, activating it to break down glycogen into glucose-1-phosphate. (correct answer)
4. It enters the nucleus and acts as a transcription factor for genes involved in glucose metabolism.

Explanation: This question tests knowledge of a specific, classic phosphorylation cascade. PKA activates phosphorylase kinase. The function of phosphorylase kinase is to phosphorylate and thereby activate glycogen phosphorylase. Glycogen phosphorylase is the enzyme that catalyzes the first step of glycogenolysis, releasing glucose-1-phosphate from glycogen stores. (A) is incorrect; adenylyl cyclase is upstream. (B) is incorrect; phosphorylase kinase is a kinase, not a phosphatase, and glycogen synthesis is inhibited, not activated, by this pathway. (D) is incorrect; phosphorylase kinase is a cytosolic enzyme whose direct target is another enzyme, not DNA.

Question 14

1. Overexpression of the wild-type version of a specific PTP, PTP1B, in the cancer cells reduces the phosphorylation of Protein X. (correct answer)
2. Treating the cells with a broad-spectrum tyrosine kinase inhibitor reduces the phosphorylation of Protein X to basal levels.
3. An in vitro assay shows that the specific activity of the tyrosine kinase Src is significantly higher in lysates from cancer cells compared to normal cells.
4. Sequencing of the gene for Protein X reveals a mutation in its phosphorylation site that makes it a better substrate for kinases.

Explanation: When you encounter questions about protein phosphorylation changes in disease, you need to distinguish between gain-of-function (kinase hyperactivation) versus loss-of-function (phosphatase inactivation) scenarios. The key is identifying which experimental approach directly tests the specific mechanism. To prove that a protein tyrosine phosphatase (PTP) is inactivated, you need to show that restoring its function reverses the hyperphosphorylation phenotype. Option A does exactly this—overexpressing wild-type PTP1B reduces Protein X phosphorylation, directly demonstrating that the phosphatase was previously unable to perform its job. This is the gold standard: if adding back a functional enzyme fixes the problem, then that enzyme was likely defective. Option B actually argues against PTP inactivation. If broad-spectrum kinase inhibition completely normalizes phosphorylation, this suggests the problem is kinase hyperactivity, not phosphatase deficiency. Option C provides direct evidence for kinase hyperactivation (elevated Src activity), which would be the alternative explanation rather than PTP inactivation. Option D identifies a substrate-level change that makes Protein X more "kinase-friendly," again pointing away from phosphatase problems. The wrong answers all either support the kinase hyperactivation hypothesis or fail to directly test phosphatase function. Remember: in biochemistry mechanism questions, the best evidence is always the "rescue experiment"—showing that restoring the suspected defective component fixes the phenotype. Look for experimental designs that directly test the proposed mechanism rather than just correlating with the outcome.

Question 15

1. Signal integration, where multiple distinct inputs are required to produce a specific output. (correct answer)
2. Signal amplification, where one kinase can activate thousands of other kinases.
3. Negative feedback, where the product of the kinase's activity inhibits the kinase itself.
4. Substrate competition, where multiple proteins compete for the same active site.

Explanation: When you encounter questions about kinase regulation, focus on how cells control these critical signaling enzymes through multiple simultaneous mechanisms. CDK2 regulation perfectly illustrates how cells ensure precise control over important processes like cell division. The correct answer is A because CDK2 requires multiple distinct inputs working together to achieve full activation. Think of it like a security system requiring both a key card AND a PIN code. CDK2 needs: (1) Cyclin A binding for partial activity, (2) activating phosphorylation at Thr-160 by CAK for full activity, and (3) absence of inhibitory phosphorylation at Tyr-15. Each input is different in nature (protein binding vs. phosphorylation events), and all must align for proper function. This integration allows cells to coordinate CDK2 activity with multiple cellular conditions. Option B is wrong because this describes a kinase cascade where one enzyme activates many others downstream—that's not what's happening with CDK2's own regulation. Option C is incorrect because negative feedback would involve CDK2's products somehow inhibiting CDK2 itself, but the question describes external regulatory mechanisms, not self-inhibition. Option D is wrong because substrate competition involves multiple proteins competing for the same binding site, while CDK2 regulation involves distinct regulatory sites and mechanisms. Study tip: When you see multiple regulatory mechanisms acting on one enzyme (binding partners, activating phosphorylation, inhibitory phosphorylation), think "signal integration." This pattern appears frequently in biochemistry—cells rarely rely on single switches for important decisions.

Question 16

1. Feed-forward activation.
2. Cross-talk inhibition between two separate pathways.
3. A dominant negative effect from a mutant protein.
4. Negative feedback inhibition. (correct answer)

Explanation: This is a classic example of negative feedback. The activation of the pathway (signal) leads to a downstream event (kinase activation) that ultimately circles back to inhibit an early step in the same pathway (receptor activity). This serves to dampen or terminate the signal in response to its own output, preventing overstimulation. It is not feed-forward (A), which typically involves one branch of a pathway priming another. It is not cross-talk (B) because it occurs within a single pathway. It is not a dominant negative effect (C), which relates to mutant proteins interfering with wild-type ones.

Question 17

1. The mutant would show enhanced and prolonged activation because it retains positive autoregulation while losing negative autoregulation (correct answer)
2. The mutant would show normal initial activation but faster signal termination due to loss of positive autoregulation
3. The mutant would show reduced activation because Site B autophosphorylation is required for full kinase maturation
4. The mutant would show identical kinase activity because Site A and Site B effects would be compensatory in normal conditions

Explanation: When you encounter questions about protein kinase regulation, focus on understanding how autophosphorylation creates feedback loops that fine-tune enzyme activity. Protein kinases often have multiple autophosphorylation sites that work together to control both the magnitude and duration of their activation. In this PKC scenario, you have two competing autophosphorylation events: Site A creates positive feedback (enhancing activity), while Site B creates negative feedback (reducing activity). When the mutant loses Site B autophosphorylation capability, it essentially removes the "brakes" from the system while keeping the "accelerator" intact. The correct answer is A because the mutant retains the positive autoregulation from Site A that amplifies kinase activity, but loses the negative autoregulation from Site B that would normally dampen the response. This creates enhanced activation (stronger signal) that persists longer because the natural termination mechanism is impaired. Answer B incorrectly suggests Site B provides positive autoregulation, when the question clearly states it decreases activity. Answer C misinterprets Site B's role - since Site B decreases activity, losing it wouldn't reduce overall activation. Answer D assumes the effects are perfectly balanced under normal conditions, but this ignores that removing negative feedback would shift the equilibrium toward sustained activation. Remember that regulatory mechanisms in biochemistry often involve competing positive and negative feedback loops. When analyzing mutants that disrupt these systems, consider which feedback mechanism is lost and how that shifts the overall regulatory balance.

Question 18

1. K2 would show the greatest increase in phosphorylation, leading to enhanced signal amplification through the cascade (correct answer)
2. All three kinases would show equal increases in phosphorylation and activity levels
3. K1 would show the greatest increase because it controls the upstream activation of the entire cascade
4. K3 and the target would show the greatest response because they are furthest downstream in the amplification cascade

Explanation: When analyzing phosphorylation cascades with phosphatase inhibitors, you need to consider both the cascade amplification and the relative affinities of each kinase for its phosphatase. The key insight is that kinases with higher phosphatase affinity are normally more tightly regulated and will show the most dramatic response when that regulation is removed. In this cascade, K2 has 10-fold higher affinity for its phosphatase than K1 or K3. This means K2 is normally kept in a more dephosphorylated (inactive) state compared to the other kinases. When you add a general phosphatase inhibitor, all phosphatases are blocked equally, but K2 will experience the greatest relative change in its phosphorylation status. Since K2 sits in the middle of the cascade, its increased activity will amplify the signal passing through to K3 and the final target. Answer A correctly identifies that K2 shows the greatest increase in phosphorylation due to its high phosphatase affinity, leading to enhanced signal amplification. Answer B is wrong because the kinases have different phosphatase affinities, so they won't respond equally. Answer C incorrectly assumes that upstream position matters more than phosphatase affinity - while K1 initiates the cascade, it doesn't have the highest affinity for phosphatase. Answer D focuses only on cascade position and ignores the critical phosphatase affinity differences. Remember: in enzyme regulation questions, always consider both the biochemical properties (like binding affinities) and the pathway architecture together - one factor alone rarely determines the outcome.

Question 19

1. Apply both serine/threonine and tyrosine phosphatases simultaneously to reset the protein to its basal state
2. Apply only serine/threonine phosphatase to remove the activating phosphorylation while maintaining the inhibiting signal
3. Apply only tyrosine phosphatase to remove the inhibiting phosphorylation while maintaining the activating signal (correct answer)
4. Apply neither phosphatase because the protein is already maximally phosphorylated on both activating and inhibiting sites

Explanation: The correct answer is C. To maximize target protein activity, you want to maintain the activating Ser-100 phosphorylation while removing the inhibiting Tyr-200 phosphorylation. Tyrosine phosphatase will specifically remove the inhibitory phosphorylation while leaving the activating serine phosphorylation intact. A is incorrect because removing both phosphorylations returns to basal state, not maximum activity. B is incorrect because removing the activating phosphorylation while keeping the inhibitory one would minimize activity. D is incorrect because having both activating and inhibiting phosphorylations results in intermediate activity, not maximum activity.

Question 20

1. The cascade allows for rapid signal termination through coordinated phosphatase action at multiple levels
2. The cascade provides massive signal amplification, converting one initial signal into 960 phosphorylated effector proteins per second (correct answer)
3. The cascade ensures substrate specificity by requiring multiple sequential phosphorylation events for activation
4. The cascade reduces ATP consumption by distributing phosphorylation reactions across multiple enzyme active sites

Explanation: The correct answer is B. The cascade provides signal amplification: 1 initial kinase → 10 second-tier kinases → 80 third-tier kinases → 960 effector proteins per second (10 × 8 × 12 = 960). This massive amplification is a key advantage of kinase cascades. A is incorrect because rapid termination is not the primary advantage over direct phosphorylation. C is incorrect because substrate specificity could be achieved through direct phosphorylation with appropriate kinase specificity. D is incorrect because the cascade actually consumes more ATP than direct phosphorylation, not less.